Neuropsychological Performance Among Individuals at Clinical High-Risk for Psychosis vs Putatively Low-Risk Peers With Other Psychopathology: A Systematic Review and Meta-Analysis.
Zachary B MillmanCaroline RoemerTeresa VargasJason SchiffmanVijay Anand MittalJames M GoldPublished in: Schizophrenia bulletin (2022)
Neurocognitive impairment in CHR cohorts should be interpreted cautiously when psychosis or even CHR status is the specific clinical syndrome of interest as these impairments most likely represent a transdiagnostic vs psychosis-specific vulnerability.